159 related articles for article (PubMed ID: 23540379)
1. Hepatitis C genotype 4 with normal transaminases: correlation with fibrosis and response to treatment, a cohort Egyptian study of 4277 patients.
Abdel-Rahman M; Saad Y; El-Raziky M; Zayed N; El-Akel W; Said M; El-Beshlawy M; Esmat G
Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):479-84. PubMed ID: 23540379
[TBL] [Abstract][Full Text] [Related]
2. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
3. FibroScan, APRI, FIB4, and GUCI: Role in prediction of fibrosis and response to therapy in Egyptian patients with HCV infection.
Yosry A; Fouad R; Alem SA; Elsharkawy A; El-Sayed M; Asem N; Hassan E; Ismail A; Esmat G
Arab J Gastroenterol; 2016 Jun; 17(2):78-83. PubMed ID: 27353055
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C Viral Kinetic Changes in a Retrospective Cohort Study of Chronic Hepatitis C Virus Egyptian Patients on Pegylated Interferon and Ribavirin Therapy.
Esmat GE; Al Akel W; Abdel Aziz RA; Al Sayed Taha A; Sabry D; Rashed LA; Mostafa A; El Kazaz AY; Ahmed SH
J Interferon Cytokine Res; 2016 Mar; 36(3):149-58. PubMed ID: 26982165
[TBL] [Abstract][Full Text] [Related]
5. Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.
El Raziky M; Attia D; El Akel W; Shaker O; Khatab H; Abdo S; Elsharkawy A; Esmat G
Arab J Gastroenterol; 2013 Sep; 14(3):94-8. PubMed ID: 24206736
[TBL] [Abstract][Full Text] [Related]
6. The assessment of data mining for the prediction of therapeutic outcome in 3719 Egyptian patients with chronic hepatitis C.
Zayed N; Awad AB; El-Akel W; Doss W; Awad T; Radwan A; Mabrouk M
Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):254-61. PubMed ID: 23141214
[TBL] [Abstract][Full Text] [Related]
7. Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective study.
Papastergiou V; Stampori M; Lisgos P; Pselas C; Prodromidou K; Karatapanis S
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):798-805. PubMed ID: 23395996
[TBL] [Abstract][Full Text] [Related]
8. Clinical, biochemical and pathological profiles of 5464 Egyptian chronic hepatitis C-infected patients.
Mabrouk M; El-Raziky M; Zayed N; Salama R; El-Akel W; Awad T; El Beshlawy M; Esmat G
Hepatogastroenterology; 2013 Oct; 60(127):1731-5. PubMed ID: 24634943
[TBL] [Abstract][Full Text] [Related]
9. Female patients in fertile age with chronic hepatitis C, easy genotype, and persistently normal transaminases have a 100% chance to reach a sustained virological response.
Floreani A; Cazzagon N; Boemo DG; Baldovin T; Baldo V; Egoue J; Antoniazzi S; Minola E
Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):997-1003. PubMed ID: 21915057
[TBL] [Abstract][Full Text] [Related]
10. Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy.
Liang CC; Liu CH; Chung CS; Lin CK; Su TH; Yang HC; Liu CJ; Chen PJ; Chen DS; Kao JH
J Infect Dis; 2015 May; 211(9):1429-36. PubMed ID: 25387585
[TBL] [Abstract][Full Text] [Related]
11. Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis.
Derbala M; Amer A; Bener A; Lopez AC; Omar M; El Ghannam M
J Viral Hepat; 2005 Jul; 12(4):380-5. PubMed ID: 15985008
[TBL] [Abstract][Full Text] [Related]
12. High sustained virological response rate to combination therapy in genotype 1 patients with histologically mild hepatitis C.
Gheorghe L; Iacob S; Grigorescu M; Sporea I; Sirli R; Damian D; Gheorghe C; Iacob R
J Gastrointestin Liver Dis; 2009 Mar; 18(1):51-6. PubMed ID: 19337634
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
Sagnelli E; Pisaturo M; Stanzione M; Messina V; Alessio L; Sagnelli C; Starace M; Pasquale G; Coppola N
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1174-1180.e11. PubMed ID: 23591280
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment.
Derbala MF; Amer AM; Almohanadi M; John A; Amin A; John A; Sharma M; Alkaabi SR; Al Dweik NZ; Pasic F; Yaqoob R; Butt MT; Shebl FM
J Viral Hepat; 2011 Jul; 18(7):e258-62. PubMed ID: 21108700
[TBL] [Abstract][Full Text] [Related]
15. Persistent transaminase elevations in chronic hepatitis C patients with virological response during peginterferon and ribavirin therapy.
Su WP; Peng CY; Lai HC; Liao KF; Huang WH; Chuang PH; Chen CB; Jeng LB
Hepatogastroenterology; 2009; 56(91-92):798-801. PubMed ID: 19621705
[TBL] [Abstract][Full Text] [Related]
16. Serum alpha-foetoprotein level predicts treatment outcome in chronic hepatitis C.
Males S; Gad RR; Esmat G; Abobakr H; Anwar M; Rekacewicz C; El Hoseiny M; Zalata K; Abdel-Hamid M; Bedossa P; Pol S; Mohamed MK; Fontanet A
Antivir Ther; 2007; 12(5):797-803. PubMed ID: 17713163
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of elevated alpha-foetoprotein (AFP) in patients with chronic hepatitis C without hepatocellular carcinoma in upper EGYPT.
Kobeisy MA; Morsy KH; Galal M; Sayed SK; Ashmawy MM; Mohammad FM
Arab J Gastroenterol; 2012 Jun; 13(2):49-53. PubMed ID: 22980591
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive fibrosis assessment predicts sustained virological response to telaprevir with pegylated interferon and ribavirin for chronic hepatitis C.
Ogawa E; Furusyo N; Shimizu M; Ihara T; Hayashi T; Harada Y; Toyoda K; Murata M; Hayashi J
Antivir Ther; 2015; 20(2):185-92. PubMed ID: 24941012
[TBL] [Abstract][Full Text] [Related]
19. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
Omran MM; Farid K; Emran TM; Attallah AA
Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
[TBL] [Abstract][Full Text] [Related]
20. Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse.
Basso M; Giannini EG; Torre F; Blanchi S; Savarino V; Picciotto A
Hepatology; 2009 May; 49(5):1442-8. PubMed ID: 19350657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
